Effects of the cationic polymers on blood pressure in rats.
- Bartlomiej Kalaska (703331)
- Kamil Kaminski (703332)
- Emilia Sokolowska (703333)
- Dominik Czaplicki (703334)
- Monika Kujdowicz (703335)
- Krystyna Stalinska (5662402)
- Joanna Bereta (112393)
- Krzysztof Szczubialka (703336)
- Dariusz Pawlak (703337)
- Maria Nowakowska (703338)
- Andrzej Mogielnicki (703339)
Publication date
March 2015
DOIAbstract
<p>MBP change registered 60 min after iv administration of Dex40-GTMAC2 (4.2 and 12.5 mg·kg<sup>-1</sup>), Dex40-GTMAC3 (2.5, 7.5, and 22.5 mg·kg<sup>-1</sup>), Dex6-GTMAC (9.6 and 28.8 mg·kg<sup>-1</sup>), GCD-GTMAC2 (10.8 and 32.4 mg·kg<sup>-1</sup>), and protamine (3.0 and 9.0 mg·kg<sup>-1</sup>) (A) and UFH (300 U·kg<sup>-1</sup>) followed by the injection of Dex40-GTMAC2 (12.5 mg·kg<sup>-1</sup>), Dex40-GTMAC3 (7.5 mg·kg<sup>-1</sup>), Dex6-GTMAC (9.6 mg·kg<sup>-1</sup>), GCD-GTMAC2 (10.8 mg·kg<sup>-1</sup>), and protamine (3.0 mg·kg<sup>-1</sup>) (B), a-P<0.05, b-P<0.01 vs. vehicle, Mann-Whitney test. Results are shown as mean ±SD, n = 4–6.</p
Add to ORKG